Simultaneous patent foramen ovale and left atrial appendage closure

Journal of Cardiovascular Medicine

Volumn 13, Issue 10, 2012, Pages 663-664

  Versaci, Francesco ^a   Saccà, Salvatore ^b   Mugnolo, Antonio ^b   Pacchioni, Andrea ^b   Reimers, Bernhard ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Ospedale Civile di Mirano   (Italy)

Author keywords

Device; embolism; left atrial appendage; patent foramen ovale; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PANTOPRAZOLE; WARFARIN;

AGED; ANEMIA; ANTICOAGULANT THERAPY; BRAIN ISCHEMIA; CASE REPORT; CATHETER; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESOPHAGITIS; FAMILY HISTORY; FLUOROSCOPY; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT ATRIUM APPENDAGE; HEART SURGERY; HISTOPATHOLOGY; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE; LETTER; MALE; PATENT FORAMEN OVALE; PATIENT SELECTION; PHYSICAL EXAMINATION; RHEUMATOID ARTHRITIS; SEPTAL OCCLUDER; STOMACH EROSION; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING; VALSALVA MANEUVER;

AGED; ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; RECURRENCE; SEPTAL OCCLUDER DEVICE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84866357968     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32834cad8d     Document Type: Letter

References (8)

1. Majunke N, Wallenborn J, Wunderlich N, Sievert H. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage. Minerva Cardioangiol 2009; 57:103-115.
2. Bayard YL, Ostermayer SH, Hein R, et al. Percutaneous devices for stroke prevention. Cardiovasc Revasc Med 2007; 8:216-225.
3. Wahl A, Krumsdorf U, Meier B, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005; 45:377-380.
4. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004; 44:750-758.
5. Chiam PT, Ruiz CE. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation. J Invasive Cardiol 2008; 20:109-113.
6. Yan BP, Kiernan TJ, Gonzales-Cruz I, Lam YY. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation. Expert Rev Med Devices 2009; 6:611-620.
7. Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and Continued Access Registry. Circulation 2011; 123:417-424.
8. Paulo M, Garcia E, Hernandez-Antolin RA, Almeria C. Simultaneous percutaneous closure of patent foramen ovale and left atrial appendage. Rev Esp Cardiol 2001. [Epub ahead of print]